A mutant neomycin phosphotransferase II gene reduces the resistance of transformants to antibiotic selection pressure.
The neo (neomycin-resistance) gene of transposon Tn5 encodes the enzyme neomycin phosphotransferase II (EC 2.7.1.95), which confers resistance to various aminoglycoside antibiotics, including kanamycin and G418. The gene is widely used as a selectable marker in the transformation of organisms as diverse as bacteria, yeast, plants, and animals. We found a mutation that involves a glutamic to aspartic acid conversion at residue 182 in the protein encoded by the chimeric neomycin phosphotransferase II genes of several commonly used transformation vectors. The mutation substantially reduces phosphotransferase activity but does not appear to affect the stability of the neomycin phosphotransferase II mRNA or protein. Plants and bacteria transformed with the mutant gene are less resistant to antibiotics than those transformed with the normal gene. A simple restriction endonuclease digestion distinguishes between the mutant and the normal gene.
Yenofsky
R L
RL
Phytogen, Pasadena, CA 91105.
Fine
M
M
Pellow
J W
JW
D000900:Anti-Bacterial Agents / Q000494:pharmacology*; D002478:Cells, Cultured; D002678:Chimera; D004352:Drug Resistance, Microbial / Q000235:genetics; D004926:Escherichia coli / Q000187:drug effects / Q000235:genetics* / Q000254:growth & development; D005798:Genes, Bacterial; D005822:Genetic Vectors; D019868:Kanamycin Kinase; D009154:Mutation; D010770:Phosphotransferases / Q000235:genetics*; D010947:Plants, Toxic; D010957:Plasmids; D011401:Promoter Regions, Genetic; D013728:Terminator Regions, Genetic; D014026:Nicotiana / Q000201:enzymology / Q000235:genetics; D014170:Transformation, Genetic
D000900:Anti-Bacterial Agents; D010770:Phosphotransferases; D019868:Kanamycin Kinase